Better Understand the Symptoms and Care Options for Irritable Bowel Syndrome
Thu, Aug 26
|Various Locations
This activity will provide physicians and mid-level providers a good foundation of the symptoms, diagnostic approaches and treatment therapies for chronic idiopathic constipation) patients with irritable bowel syndrome with diarrhea (IBS-D)and IBS-C (constipation) Special emphasis will be placed on
Time & Location
Aug 26, 2021, 6:30 PM – Mar 09, 2022, 8:45 PM
Various Locations
About the Event
Target Audience
Internists, Family Physicians, Gastroenterologists, Physician Assistants, Nurse Practitioners and RN’s.
Program Agenda (Times May Vary)
6:30 – 7:00pm
Registration and Check-in
7:00 – 7:15pm
Welcome and Introductions - Dinner is served
7:30 – 8:30pm
Presentation
• An overview of Irritable Bowel Syndrome (IBS-c and IBS-D)
o Epidemiology
o Clinical Presentation
o Adult and Pediatric Patients
• Pathogenesis of IBS-D and IBS-C
• An updated classification system for IBS, the Rome IV diagnostic criteria
• Management of IBS and CIC Patients
o Dietary approaches
o Anti-spasmodic therapies
o Dietary fiber supplements
o Behavioral approaches
• Recently approved therapeutic agents for IBS-D and IBS-C
• Patient care management for Advanced-practice clinicians and specialty nurses
• Introduction and explanation of sucrase isomaltase deficiency and how to avoid mistaking it for IBS-D
• When and how to refer a patient for more advanced care, diagnostics and treatment
• Questions and Discussion on clinical cases
• Re-Cap and Closing comments
8:30 – 8:45pm
Collegial Discussion and Networking
8:45pm
Program adjourns
Learning Objectives
As a result of participating in this activity, participants should be able to:
1. Explore the pathways and symptoms of those with Irritable Bowel Syndrome with Diarrhea and Constipation
2. Summarize the underlying physiologic and psychological determinants of IBS symptoms.
3. Identify patients with IBS-C and IBS-D who are appropriate candidates for pharmacotherapy.
4. Review the diagnostic criteria and available tests.
5. Investigate behavioral approaches to address the stressors that may increase IBS symptoms and ways to minimize the effect.
6. Develop individualized treatment plans for patients with IBS and CIC by applying new clinical data.
7. Explore sucrase isomaltase (SI) deficiency and its similar symptoms to IBS-D
8. Assist patients and their families to recognize the causes and treatments for IBS so they can partner with clinicians to manage symptoms and treatment - especially important for younger patients.
9. Review the benefits, efficacy, safety and mechanism of action of the most current FDA approved treatment options and OTC options.
10. Recognize when to refer patients to GI specialists and what therapeutic options may be available.
Registration Fees
There is no fee to attend this event but advance registration is requested to allow for event planning.
To Register
Click on a date and location below to register for a program.
If online registration has closed you may still attend the event by registering as a walk-in the day of the program.
August 26, 2021 – Costa Mesa, CA
Venue – Grand Garden Restaurant
Faculty: Fouad Moawad, MD Scripps Health, La Jolla, CA
View the Course Flyer (Available Soon)
October 6, 2021 – Miami, FL
Venue – University of Miami Miller School of Medicine
Faculty: Anthony Lembo, MD Harvard University
View the Course Flyer (Available Soon)
October 13, 2021 – Falls Church, VA
Venue - Maggiano’s Little Italy-Tyson’s Galleria
Faculty: Anthony Lembo, Harvard University
View the Course Flyer (Available Soon)
December 9, 2021 – Houston, TX
Venue - TBD
Faculty: TBD
View the Course Flyer (Available Soon)
February 16, 2022 – Ft Lauderdale, FL
Venue - TBD
Faculty: Carol M. Antequera DMSc PA-C, University of Miami
View the Course Flyer (Available Soon)
March 9, 2022 – Houston TX – Academy of Family Physicians
Venue – Maggiano’s Little Italy-Post Oak
Faculty: Brooks Cash, MD , University of Texas Health Science Center
View the Course Flyer (Available Soon)
Joint Provider Statement
UofL CMEPD logoThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and SC Liver Research Consortium. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The University of Louisville School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses - This program has been approved by the Kentucky Board of Nursing for 1.2 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-22-1226. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation.
Jointly Provided By
Acknowledgments
This activity has been supported by an educational grant from Salix.